CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans

被引:15
作者
Ito, S
Pedras-Vasconcelos, J
Klinman, DM
机构
[1] US FDA, Ctr Biol Evaluat & Res, Sect Retroviral Immunol, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA
关键词
D O I
10.1128/IAI.73.9.6154-6156.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Synthetic oligodeoxynucleotides containing CpG motifs trigger an innate immune response that typically increases host resistance to infection. Yet CpG treatment reduces the resistance of normal mice to Candida albicans infection. This effect is mediated by CpG-induced interleukin-12, indicating that CpG-dependent cytokine production may have adverse consequences for the host.
引用
收藏
页码:6154 / 6156
页数:3
相关论文
共 26 条
[1]   Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice [J].
Anders, HJ ;
Vielhauer, V ;
Eis, V ;
Linde, Y ;
Kretzler, M ;
de Lema, GP ;
Strutz, F ;
Bauer, S ;
Rutz, M ;
Wagner, H ;
Gröne, HJ ;
Schlbndorff, D .
FASEB JOURNAL, 2004, 18 (01) :534-+
[2]  
Ballas ZK, 1996, J IMMUNOL, V157, P1840
[3]   CpG-oligonucleotides for cancer immunotherapy: Review of the literature and potential applications in malignant glioma [J].
Carpentier, AF ;
Auf, G ;
Delattre, JY .
FRONTIERS IN BIOSCIENCE, 2003, 8 :E115-E127
[4]   INTERLEUKIN-4 AND INTERLEUKIN-10 INHIBIT NITRIC OXIDE-DEPENDENT MACROPHAGE KILLING OF CANDIDA-ALBICANS [J].
CENCI, E ;
ROMANI, L ;
MENCACCI, A ;
SPACCAPELO, R ;
SCHIAFFELLA, E ;
PUCCETTI, P ;
BISTONI, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (05) :1034-1038
[5]   A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant [J].
Halperin, SA ;
Van Nest, G ;
Smith, B ;
Abtahi, S ;
Whiley, H ;
Eiden, JJ .
VACCINE, 2003, 21 (19-20) :2461-2467
[6]   Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha [J].
Halpern, MD ;
Kurlander, RJ ;
Pisetsky, DS .
CELLULAR IMMUNOLOGY, 1996, 167 (01) :72-78
[7]   A Toll-like receptor recognizes bacterial DNA [J].
Hemmi, H ;
Takeuchi, O ;
Kawai, T ;
Kaisho, T ;
Sato, S ;
Sanjo, H ;
Matsumoto, M ;
Hoshino, K ;
Wagner, H ;
Takeda, K ;
Akira, S .
NATURE, 2000, 408 (6813) :740-745
[8]   Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: Two unique but complementary strategies for the treatment of allergic diseases [J].
Horner, AA ;
Raz, E .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (05) :706-712
[9]  
Jahrsdorfer Bernd, 2003, Curr Opin Investig Drugs, V4, P686
[10]   Immunotherapeutic uses of CpG oligodeoxynucleotides [J].
Klinman, DM .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (04) :248-257